Introduction
Cellular exposure to the adenine analog 2-aminopurine (2-AP) has been shown to result in loss of DNA damage-induced cell cycle control through unknown mechanisms. In the presence of 2-AP, baby hamster kidney cells were able to bypass G 1 , G 2 , S, or M phase arrest induced by drug treatments (Andreassen and Margolis, 1992) . 2-AP was also shown to reduce gamma irradiation (gIR)-induced G 2 /M arrest in murine Tlymphoma cells, resulting in an elevated degree of DNA fragmentation after 24 h of treatment (Palayoor et al., 1995) . The ability of 2-AP to affect ionizing radiationinduced expression of GADD45, a protein implicated in the initiation of a p53-dependent G 2 /M arrest, has also been documented (Carrier et al., 1998) . These findings suggest that certain cellular targets of 2-AP may play important roles in regulating cell cycle checkpoints in response to DNA damage. Independent of its effects on cell cycle control, 2-AP has also been shown to act as a kinase inhibitor. In fact, the other well-demonstrated cellular effect of 2-AP is its ability to inhibit the ATPdependent phosphorylation of the a subunit of eukaryotic initiation factor 2 (eIF-2a) by the interferon (IFN)-inducible double-stranded RNA (dsRNA)-dependent protein kinase (PKR) (Thomis and Samuel, 1993; Hinnebusch et al., 2000) .
The tumor suppressor p53 is a DNA damageinducible transcription factor, whose targets include p21 WAF1/CIP1 Vousden, 2000) , GADD45 and 14-3-3s (Hermeking et al., 1997) , which are involved in G 1 /S and G 2 / M arrest, and Bax (Zhang et al., 2000) and p53AIP1 (Oda et al., 2000) , which are implicated in cellular apoptosis. Under normal conditions, p53 activity is not essential for normal cell growth and differentiation. However, when cells sustain genotoxic stress, p53 becomes activated, and in turn activates its downstream targets to either induce cell cycle arrest or programmed cell death, depending on the severity of the DNA insult . When the DNA damage can still be repaired, cell cycle arrest would be induced until the damage is mended, whereas if the DNA damage is too profound, then apoptotic death pathways are triggered. Since gene regulation by p53 can mean life or death for cells following DNA injury (Vousden and Lu, 2002) , the functioning of p53 itself must be tightly regulated. Cells have evolved several ways to control p53, including regulation of its transcription and translation. However, the primary method by which p53 activity is regulated is by controlling its stability (Vousden et al., 2000) . p53 is a protein of high turnover rate, because of its rapid degradation by the proteasome pathway. Under normal conditions, Mdm2, which possesses E3 ubiquitin ligase activity, ubiquitinates and targets nuclear p53 for degradation (Vousden et al., 2000) . During DNA damage, however, p53 undergoes post-translational modifications that facilitate the stabilization of its protein levels in cells (Shieh et al., 1997) . For most cells, this step facilitates the full activation of p53's transcriptional regulatory activity toward downstream targets. One well-established model of these posttranslational modifications is the phosphorylation of p53 by ATM (Banin et al., 1998; Canman et al., 1998) , ATR (Tibbetts et al., 1999) , and Chk2/Cds1 (Chehab et al., 2000; Hirao et al., 2000; Shieh et al., 2000) at the residues Ser15 and Ser20 in human p53 (Ser18 and Ser23 in mice, respectively). These phosphorylations have been postulated to interfere with Mdm2 binding to, and/or nuclear export of, p53 (Zhang and Xiong, 2001) , thereby preventing p53 inactivation and degradation through the proteasome pathway.
Our laboratory previously showed that the eIF-2a kinase PKR physically interacts with p53 and induces the phosphorylation of p53 on Ser392 in vitro (Cuddihy et al., 1999b) . Through experiments using PKR +/+ and PKR À/À mouse embryonic fibroblasts (MEFs), we further demonstrated that PKR participates in signaling leading to p53 phosphorylation in response to DNA damage (Cuddihy et al., 1999a) . The complexity of the PKR À/À systems, however, because of the unavailability of a complete PKR knockout mouse (Baltzis et al., 2002) , prompted us to employ 2-AP in our study, which aims to acquire a better understanding of the mechanisms of PKR action in p53 activation. Here, we report that 2-AP inhibits p53 stabilization upon exposure to various forms of DNA damage in a non-cell-typespecific manner. We show that 2-AP treatment impedes the ATM-and ATR-dependent phosphorylations of p53 in vivo and inhibits ATM and ATR kinase activities in vitro. Furthermore, 2-AP inhibits p53 phosphorylation on Ser15 under specific genotoxicity-inducing conditions in ATM-DNA-PK-or ATR-deficient cells. These data reveal the existence of multiple 2-AP-sensitive pathways in DNA damage-induced activation of p53. Although 2-AP is known to inhibit PKR activity in vivo ( Thomis and Samuel, 1993; Hinnebusch, 2000) , our findings suggest that 2-AP has multiple cellular targets and its effects may not be specific to the inhibition of PKR alone. Ultimately, however, 2-AP allows cells to escape the deleterious effects of DNA damage and leads to increased clonogenic survival.
Results

DNA damage-induced p53 accumulation is compromised in the presence of 2-AP
The phenomenon of p53 accumulation in response to DNA-damage treatments has been well established in the cases of gIR, ultraviolet radiation (UV), and adriamycin (AD). To determine whether 2-AP can interfere with the stress-induced stabilization of p53, we pretreated wild-type (wt) p53-containing NIH 3T3 cells with 10 mm 2-AP or solvent only for 2 h and then exposed the cells to AD, UV, or g-radiation for various lengths of time. This concentration of 2-AP was shown to induce its observed cellular effects (Andreassen and Margolis, 1992; Jarrous et al., 1996; Strong et al., 1998; Osman et al., 1999) . Within 1 h after addition of AD in the absence of 2-AP, the protein level of p53 increased when compared to that of the cells without AD treatment (Figure 1a) . However, NIH 3T3 cells pretreated with 2-AP had a delayed and impaired p53 accumulation as compared to that in the nontreated samples (Figure 1a) . A similar phenomenon was observed upon UV and gIR treatment, where 2-AP pretreated samples have reduced stressinduced p53 accumulation ( Figure 1b and data not shown).
This effect of 2-AP was also observed in gIR-treated wt p53-containing murine pre-B 70 Z/3 cells ( Figure 1c ) and AD-treated WI-38 human diploid primary cells (Figure 1d ). Furthermore, p53-dependent activation of downstream target p21 was inhibited in the presence of 2-AP pretreatment (Figure 1c) . Hence, the ability of 2-AP to downregulate stress-induced p53 stabilization is observed in various cell types and appears to affect p53-dependent activation of downstream targets.
2-AP inhibits DNA damage-induced p53 phosphorylation
To test the possibility that 2-AP affected stress-induced p53 stabilization by inhibiting its phosphorylation at Ser15 and Ser20 (Ser18 and Ser23 in mice), we analysed p53 from NIH 3T3 cells that were exposed to DNAdamaging agents for various hours with or without 2-AP pretreatment. We used phospho-specific antibodies to detect phosphorylation at Ser18 and Ser23. In Figure 2a , cells were also preincubated with a proteasome inhibitor, MG132, in order to stabilize the endogenous p53 protein levels. Within 1 h after exposure to gIR, p53 became phosphorylated on Ser18 and Ser23 (Figure 2a) . However, these modifications were greatly reduced in the cells pretreated with 2-AP (Figure 2a) . When the cells were exposed to AD or UV with 2-AP pretreatment in the absence of MG132, Ser18 and Ser23 phosphorylations were also attenuated in the case of AD exposure, and Ser18 phosphorylation was reduced upon UV exposure (Figure 2b , c, and data not shown). A similar phenomenon was also seen in AD-treated WI-38 human primary cells in the presence of 2-AP pretreatment ( Figure 2d ).
2-AP targets ATM-dependent phosphorylation in vivo and ATM activity in vitro
Chk2 kinase has been demonstrated to phosphorylate human p53 on Ser20 (Ser23 in mice) in response to DNA damage (Chehab et al., 2000; Hirao et al., 2000; Shieh et al., 2000) . It has been shown that Chk2 can be 2-aminopurine alters cellular response to DNA damage S Huang et al phosphorylated by ATM or ATR (Abraham, 2001) , thereby becoming activated under various conditions. Since 2-AP treatment of NIH 3T3 cells reduced p53 Ser23 phosphorylation, we hypothesized that either 2-AP affected the ability of Chk2 to phosphorylate p53 or it acted upstream of Chk2. To this end, we employed an anti-Chk2 antibody that can recognize both the phosphorylated and the nonphosphorylated forms of Chk2. This antibody enables the differentiation of the phosphorylated forms of Chk2 as slower migrating 2-aminopurine alters cellular response to DNA damage S Huang et al bands in the SDS-PAGE gel from the nonphosphorylated form (Matsuoka et al., 1998) . Using NIH 3T3 cells, we found that Chk2 activation by phosphorylation was partially diminished in 2-AP pretreated cells at 2 h after either gIR or AD treatment based on the differences in Chk2 migration pattern ( Since Chk2 is downstream of ATM and functions via both ATM-dependent and ATM-independent pathways (Hirao et al., 2002) , next we wished to know whether 2-AP inhibits ATM. To this end, Flag-tagged wt ATM (i.e. Flag-ATMwt) cDNA was transiently transfected into 293T cells to allow the overexpression of the FlagATMwt protein. The protein was then immunoprecipitated with anti-Flag antibody, and engaged in kinase assays with or without 2-AP. As substrate, we chose GST-PHAS-I, which was previously shown to be phosphorylated by ATM in vitro (Banin et al., 1998; Dimitrova and Gilbert, 2000) . In the absence of 2-AP, Flag-ATMwt strongly phosphorylated GST-PHAS-I as compared to the background in the mock reaction, where the recombinant kinase is absent (Figure 3b , middle panel, compare lane 1 with lane 2). However, in the presence of 2-AP, GST-PHAS-I phosphorylation was suppressed as compared to the reaction without 2-AP ( Figure 3b , middle panel, compare lane 4 with lane 2). We also noticed that the inhibitory effect of 2-AP was dose-dependent ( Figure 3c ). In this experiment, there was a noticeable amount of nonspecific phosphorylation in the mock reaction ( Figure 3c , lane 1). However, the presence of Flag-ATMwt induced GST-PHAS-I phosphorylation threefold (lane 2) compared to background (lane 1). In addition, 10 or 5 mm of 2-AP was able to reduce phosphorylation to background levels ( Figure 3c , lanes 3 and 4), whereas Flag-ATMwt kinase activity was partially inhibited in the presence of 2 mm 2-AP (lane 5). Overall, these data demonstrated that 2-AP can indeed inhibit ATM kinase activity in vitro.
2-AP attenuates DNA damage-induced p53 stabilization in ATM and DNA-PK-deficient cells Next, we checked for AD-induced p53 phosphorylation in human GM01526E AT cells lacking endogenous ATM activity (i.e. ATM À/À cells). We hypothesized that if 2-AP only affects the ability of ATM alone to phosphorylate p53 upon induction of DNA damage, then 2-AP should not hinder any residual p53 phosphorylation that takes place in ATM-deficient cells. ATM À/À cells were incubated in MG132 to stabilize the endogenous p53 protein levels before subjected to 2-AP and AD treatments (Figure 4a ). When protein extracts were subjected to immunoblot analysis for p53 phosphorylation and protein levels, we found that induction of p53 phosphorylation on Ser15 by AD treatment was inhibited in 2-AP-treated ATM À/À cells after 3 or 6 h of exposure to DNA damage ( Figure 4a ). The induction of p53 phosphorylation in ATM À/À cells by AD shows that an ATM-independent pathway(s) exists, which lead(s) to phosphorylation of p53 on Ser15 upon DNA damage, consistent with the literature (Tibbetts et al., 1999; Vogelstein et al., 2000) . Significantly, our data showed that this pathway(s) can still be inhibited by 2-AP ( Figure 4a) .
We also performed similar experiments using SCGR11 murine cells lacking DNA-PK kinase activity (Araki et al., 1999) . We found that p53 protein levels were h and then with (+) or without (À) 2-AP (10 mm) for 2 h followed by exposure to 1 mm AD for the indicated time points. Protein extracts (50 mg) were analysed for p53 Ser15 phosphorylation and p53 levels by Western blot. (b) The DNA-PK-deficient mouse SCGR11 cells were pretreated with (+) or without (À) 2-AP (10 mm), and then incubated with 1 mm AD for the indicated h. In all, 50 mg of protein extracts were analysed by Western blotting for p53 Ser18 phosphorylation and p53 protein levels 2-aminopurine alters cellular response to DNA damage S Huang et al already stabilized in SCGR11 cells regardless of whether they were subjected to genotoxic treatments (Figure 4b ). However, p53 phosphorylation on Ser18 was still able to take place in response to AD treatment. Furthermore, 2-AP pretreatment could also attenuate the residual p53 phosphorylation on Ser18 in these cells (Figure 4b ).
2-AP inhibits ATR-dependent phosphorylation of p53
ATR kinase has been shown to play a pivotal role in contributing to p53 stabilization in response to UV irradiation (Tibbetts et al., 1999; Vogelstein et al., 2000) .
Although in AD-and gIR-induced p53 accumulation ATM is responsible for the induction of the phosphorylation event and ATR the maintenance stage, both the induction and the maintenance of p53 phosphorylation on Ser15 upon UV radiation is mostly the responsibility of ATR (Abraham, 2001) . To see whether 2-AP can interfere with ATR-mediated p53 phosphorylation and study ATR kinase activity separately from that of ATM, we used the human GM847 cell lines stably harboring doxycycline (Dox)-inducible expression vectors for Flag-ATRwt or a catalytic mutant (kd) form of Flag-ATR (Tibbetts et al., 1999) . We first verified the In any case, the addition of 2-AP also reduces the phosphorylation of the substrate to background levels (lane 3) in Flag-ATRkd-containing kinase reaction.
To check whether 2-AP can inhibit the UV-induced p53 phosphorylation on Ser15 in these cells, we induced the expression of Flag-ATRwt and ATRkd by Dox followed by pretreatment with or without 2-AP and exposure to UV radiation. We noticed that the p53 protein levels were already stabilized in GM847 cell lines independently of DNA damage, most likely because of the presence of SV40 large T antigen in these cells (Cliby et al., 1998) (Figure 5c, bottom panel) . However, the p53 Ser15 phosphorylation response was still inducible by UV (Figure 5c , top panel). We found that in cells overexpressing Flag-ATRwt, 2-AP was able to reduce UV-induced p53 Ser15 phosphorylation (compare lanes 2 and 3 with lanes 5 and 6, respectively) to the levels seen in UV-treated Flag-ATRkd expressing cells (lanes 8 and 9). When we checked the effect of 2-AP on the residual p53 phosphorylation observed in UV-treated FlagATRkd-expressing cells, we found that the kinase inhibitor was still able to further suppress Ser15 p53 phosphorylation in these cells (Figure 5d , top panel, compare lanes 2 and 3 with lanes 5 and 6, respectively). Based on the dominant-negative function of FlagATRkd in GM847 cells (Tibbetts et al., 1999) , our data suggested that 2-AP can inhibit UV-mediated p53 phosphorylation through ATR-dependent and ATRindependent pathways.
Biological implications of 2-AP treatment
To examine the biological impact of cellular exposure to 2-AP, we obtained HCT116 colon carcinoma cell lines with inactivations of p53, Bax or p21 gene by homologous recombination (Bunz et al., 1998; Zhang et al., 2000) . First, we verified that p53 activation by phosphorylation on Ser15 and Ser46 were impaired in HCT116 p53 +/+ cells pretreated with 2-AP and subjected to DNA damage by AD (Figure 6a , panels 1 and 3). Next, HCT116 p53 +/+ , p53
, p21 +/+ or p21 À/À cells were treated with AD only, 2-AP only, or 2-AP + AD and subjected to cell cycle analysis 24 h later using fluorescence-activated cell sorting (FACS). We found that AD treatment alone induced a strong G 2 /M arrest in these cell lines regardless of their p53 status (Figure 6b , panels 2 and 6). However, pretreatment with 2-AP allowed p53 +/+ cells to bypass AD-induced G 2 /M arrest, whereas this phenomenon was not observed in p53 À/À cells (Figure 6b, panel 4 vs panel 8 ). These data suggested that the ability of 2-AP-treated HCT116 cells to bypass DNA damage-induced G 2 /M arrest is a p53-dependent process. When the HCT116 p21 +/+ and p21 À/À cells were exposed to AD, we found that 2-AP pretreatment reduced the number of both cell types in G 2 suggesting that the kinase inhibitor facilitates these cells to bypass AD-induced G 2 /M arrest (Figure 6b , panels 12 and 16). However, substantial percentages of p21 À/À cells were found in S and G 2 phases under 2-AP and AD treatments probably because of an increased inability of these cells to stably arrest in G 2 and G 1 .
To check the effects of 2-AP on the clonogenic survival of HCT116 cells in the presence of DNA damage, we performed colony formation assays using the p53 +/+ , p53
, Bax À/À , p21 +/+ and p21
cell lines, which were treated as described for FACS analysis, followed by long-term incubation to allow colony formation. We found that AD treatment alone greatly reduced the survival of all six cell lines, and this killing effect was partially rescued in Bax À/À cells (Figure 6c , middle right panel). This is consistent with the role of Bax in mediating drug-induced cell death (Zhang et al., 2000) . In the condition where all cell lines were pretreated with 2-AP prior to exposure to AD, the cells were partially rescued from AD-induced cell death as compared to the cells treated with AD only (Figure 6c ). Furthermore, 2-AP also targeted DNA damage-induced p53-and p21-independent pathways, since 2-AP could also rescue p53 À/À and p2 l À/À cells from adriamycin-induced cell death (Figure 6c ).
Discussion
Previously, it has been shown that exposure to 2-AP can trigger various cell types to bypass cellular arrest induced by drug treatments or ionizing radiation through unknown mechanisms (Andreassen and Margolis, 1992; Palayoor et al., 1995) . The data we present +/+ , p53 À/À , p21 +/+ , or p21 À/À cells were incubated with 0.34 mm AD alone for 3 h, 5 mm 2-AP alone for 2 h, or pretreated with 5 mm of 2-AP for 2 h followed by the addition of 0.34 mm AD for 3 h (double treatment). After treatments, the medium was refreshed and cells were cultured for a further 24 h before they were harvested, fixed, stained with propidium iodide and subjected to cell cycle analysis by FACS. (c) Exponentially grown HCT116 cells were treated as in (b). After treatment, the medium was refreshed and cells were maintained in culture for 10-12 days until colonies were formed. The colonies were visualized by staining with Crystal Violet
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2-aminopurine alters cellular response to DNA damage S Huang et al here offer a plausible explanation to these observations, and the potential mechanisms by which these effects can be mediated. We show that 2-AP, an adenine analog that has been used as a kinase inhibitor, is able to inhibit genotoxic stress-induced p53 stabilization. It does so by inhibiting p53 phosphorylation on Ser15 and Ser20 2-aminopurine alters cellular response to DNA damage S Huang et al residues (Ser18 and Ser23 in murine p53, respectively) in a noncell-type-specific manner. Furthermore, we show that 2-AP can inhibit ATM and ATR kinase activities in vitro and impair ATM-or ATR-dependent phosphorylation in vivo. To our knowledge, this is the first paper to describe the ability of 2-AP to inhibit ATM and ATR, two Ser/Thr protein kinases that play vital roles in cellular DNA damage response and in activation of tumor suppressor p53. Several chemical agents have been shown to interfere with genotoxic stress-induced cellular responses. For instance, caffeine, a protein kinase inhibitor, has been shown to attenuate cell cycle checkpoints by inhibiting ATM-dependent phosphorylation of Chk2 in vivo and in vitro (Blasina et al., 1999) . This inhibition has been postulated to allow cells to bypass the G 2 /M checkpoint (Yao et al., 1996) by preventing Chk2 activation, thereby impeding its ability to act on downstream targets such as Cdc25C (Blasina et al., 1999) . It is through these mechanisms that caffeine has been branded as a radiosensitizer, especially in p53-deficient tumor cells (Yao et al., 1996; Blasina et al., 1999) . Wortmannin, another radiosensitizer, has also been shown to inhibit ATM kinase activity (Sarkaria et al., 1998) . Although as a kinase inhibitor, 2-AP also inhibits ATM kinase activity and thus its downstream targets, our study clearly demonstrates that the outcome of 2-AP exposure for cells under genotoxic stress is much more than its influence on the ATM pathways alone. We demonstrated here that 2-AP can also inhibit ATR. More importantly, we show that 2-AP allows wtp53-containing HCT116 colon carcinoma cells to bypass AD-induced G 2 /M checkpoint, and that it ultimately acts as a tumor promoter to allow cells to resist genotoxic stress-induced cell death. Specifically, 2-AP pretreatment allows HCT116 colon carcinoma cells to resist the killing effects of AD and results in greater clonogenic survival of the cells. First of all, our data show that AD-induced death is partially rescued in Bax À/À cells (Figure 6c ), indicating that this killing effect is in part dependent on Bax, which is a downstream target of p53 (Zhang et al., 2000) . Furthermore, we show that 2-AP can also rescue p53 À/À and p21 À/À cells from AD-induced cell death (Figure 6c ). This clearly indicates that 2-AP targets also DNA damage-induced p53-and p21-independent pathways to facilitate cellular resistance to genotoxic stress-induced cell death. Potential targets might be other members of the p53 family of proteins, namely p63 and p73, whose inactivation by homologous recombination in mice have been recently shown to abolish AD-induced apoptosis (Flores et al., 2002) . Our data also suggest that p53 phosphorylation may be necessary but not sufficient for DNA damageinduced apoptosis. For example, 2-AP attenuates ADinduced p53 phosphorylation on Ser46 (Figure 6a, panel  3) , a phosphorylation event that was shown to be required for p53-mediated apoptosis in response to DNA damage (Oda et al., 2000) . Inasmuch as 2-AP prevents DNA damage-induced cell death in HCT116 cells independently of p53, downregulation of p53-dependent death pathways by inhibiting Ser46 phosphorylation had most likely contributed to the overall increase in clonogenic survival of the cells, taking into account that DNA damage induces both p53-dependent and -independent cellular response pathways.
2-AP has been extensively used as a selective and potent inhibitor of PKR (Hu and Conway, 1993; Jarrous et al., 1996; Osman et al., 1999; Ben-Asouli et al., 2002) . PKR is a Ser/Thr kinase expressed constitutively at low levels in most cells but is induced by viruses, dsRNA, and IFN (Kaufman, 2000) . 2-AP prevents the establishment of the antiviral state in IFNtreated cells (Wathelet et al., 1989) and has been instrumental in several functional studies of PKR, such as elucidating the ability of PKR to regulate the expression of tumor necrosis factor-a gene (Jarrous et al., 1996; Osman et al., 1999) , the activation of transcription factor NF-kB (Cheshire et al., 1999) , or explaining the role of PKR in reovirus-mediated oncolysis of tumor cells (Strong et al., 1998) . Our previous studies correlated the absence of wt PKR function with downregulation of two p53 downstream targets, p21 and mdm2 genes and a partial reduction of stress-induced p53 phosphorylation on serine 18 (Cuddihy et al., 1999a) . However, we have not as yet obtained evidence showing which p53 activation pathway(s) utilizes PKR. This limitation is largely because of the lack of a complete PKR knockout system as mentioned previously (Baltzis et al., 2002) . In addition, loss of PKR function can be substituted by the expression of other PKR-like molecules (Kaufman, 2000) . One such candidate is the PKR-like endoplasmic reticulum (ER) kinase, PERK, which shares 40% sequence homology at its cytoplasmic/nuclear catalytic domain with the eIF2a kinase domain of PKR (Harding et al., 1999 . It is an ER-resident kinase that plays a role in mediating translational inhibition in response to ER stress triggered by conditions such as glucose starvation or viral oncogenesis . PERK has also recently been shown to mediate UVinduced phosphorylation of eIF-2a, thereby inhibiting translation (Wu et al., 2002) . Another candidate is the eIF-2a kinase GCN2 that regulates protein synthesis in response to various forms of stress including amino-acid starvation (Hinnebusch, 2000) , and UV irradiation (Deng et al., 2002) . Although 2-AP is a potent inhibitor of PKR activity, it also targets kinases that are involved in genotoxic stress response pathways including ATM or ATR. In regard to ATR, our in vivo studies were focused on cells expressing the dominant-negative ATRkd mutant because of the unavailability of ATR À/À cells resulted from the embryonic lethality of the ATR knockout mice (Brown and Baltimore, 2000; de Klein et al., 2000) . Our findings with the Flag-ATRkd expressing cells should be interpreted with some caution since the ATR catalytic mutant may not exhibit a complete dominant-negative effect in all cells, a limitation that has been recently reported for some cells expressing the ATRkd mutant (Nghiem et al., 2002) .
In summary, our data provide strong evidence that 2-AP acts as a tumor promoter by interfering with DNA damage-induced p53 response pathways in the short run, as well as p53-independent responses in the long term. Ultimately, this results in cellular resistance to DNA damage-induced cell death and increased clonogenic survival. Moreover, our study reveals that 2-AP affects multiple pathways in genotoxic stress-induced cellular responses and therefore, it may prove a useful tool in the characterization of these responses.
Materials and methods
Cell culture
NIH 3T3 and SCGR11 cells were maintained in Dulbecco's modified Eagle's medium (DMEM) (Life Technologies, Inc.) supplemented with 10% calf serum (CS) (Life Technologies), and 50 IU/ml penicillin/streptomycin (Pen/Strep) (ICN Biomedicals, Inc.). 70Z/3 cells were maintained in RPMI 1640 (Life Technologies) containing 10% fetal bovine serum (FBS) (Life Technologies), 50 mm of b-mercaptoethanol (b-ME) (Sigma), and 50 IU/ml Pen/Strep. GM01526E AT cells were kept in culture in conditions similar to those for 70Z/3 cells but without b-ME. GM847 Flag ATR wt and kd cells were grown in DMEM containing 10% tetracycline-system approved FBS (Clonetech), 1% l-Glutamine (l-Gln) (Cellgro), 50 IU/ml of Pen/Strep, and 400 mg/ml of active Geneticin (G418) (Gibco). HT116 cells were grown in McCoy's 5A medium (Cellgro) containing 10% FBS and 50 IU/ml Pen/Strep. 293T cells were grown in Alpha modification of Eagle's medium containing 10% FBS, 1 mm l-Gln, and 50 IU /ml Pen/Strep, whereas WI-38 human diploid primary cells in minimum essential medium Eagle containing 10% FBS and 50 IU/ml Pen/Strep.
Cell treatments
2-AP (Sigma) was prepared at 200 mm stock concentration by dissolving it in 50 mm NaOH. The final 2-AP treatment concentration was 2-10 mm as indicated (Andreassen and Margolis, 1992; Jarrous et al., 1996; Strong et al., 1998; Osman et al., 1999; Dimitrova and Gilbert, 2000) . Non-2-AP-treated cells were incubated with sterile NaOH at final concentrations of 0.5-2.5 mm as control to ensure that they were exposed to the same amount of NaOH as the 2-AP-treated cells. This concentration of NaOH did not significantly affect the pH of the media. The proteasome inhibitor MG132 (Biomal) was dissolved in dimethyl sulfoxide (DMSO) and used at a final concentration of 20 mm. AD stock was also dissolved in DMSO, diluted in 1 Â phosphate-buffered saline (PBS) and used at a final concentration of 1 or 0.34 mm as indicated. In 2-AP and UV experiments, following pretreatment with 2-AP as previously described, the cell medium was removed and saved, and the cells were exposed to 50 J/m 2 UV radiation in a Stratagene UV Crosslinker. The cells were then incubated in their original media in the 371C incubator for the indicated time. In 2-AP and gIR experiments, following pretreatment with 2-AP, and proteasome inhibitor when indicated, cells were collected in 15 ml Falcon tubes and exposed to 50 Gy of gIR, and then incubated for the indicated time. Induction of Flag-ATRwt or ATRkd expression in GM847 cells was performed by incubation with 1 mg/ml doxycycline (Sigma) for 24 to 32 h prior to treatments. 70 Z/3 cells, GM01526E AT cells, SCGR11, GM847, HCT116, and WI-38 cells were treated in a similar fashion as described, except that nonadherent cells were treated in flasks instead of plates. Each experiment was repeated at least three times.
Transfection
Transient transfections of 293T cells with mock plasmid pCDNA3.1 Zeo-Flag and pCDNA3 Flag-ATMwt plasmid were performed using LipofectAMINE PLUS reagent (Life Technologies) according to the protocol described for this product from the company.
Protein extraction and immunoblottings
Cells were washed once with ice-cold PBS and then extracted with lysis buffer consisting of 50 mm HEPES pH 7.4, 150 mm NaCl, 0.1 mm EDTA, 0.5% NP-40, 2 mg/ml leupeptin, 2 mg/ml pepstatin, 3 mg/ml aprotinin, 1 mm DTT, 0.02 mm okadaic acid, 1 Â of 50 Â complete protease inhibitor cocktail tablet, 0.1 mm Na 3 VO 4 , and 1 mm PMSF. For lysis of 293T cells transfected with pCDNA3 Flag-ATMwt or pCDNA3.1 Zeo-Flag (mock) 2-aminopurine alters cellular response to DNA damage S Huang et al plasmids and GM847 cells, TGN buffer was used as described (Canman et al., 1998) .
Western blots were performed according to standard protocol (Sambrook et al., 1989) using anti-p53 (Ab-1) mAb (Oncogene), anti-p53 (FL-393) rabbit polyclonal antibody (pAb) SC-6243 (Santa Cruz), anti-p53 Ser15 pAb (Cell Signaling), anti-p53 Ser20 pAb (Cell Signaling), anti-p53 Ser46 pAb, anti-Chk2 pAb (a gift from Dr Stephen J Elledge, Baylor College of Medicine, Houston, TX, USA), anti-p21 (C-19) pAb (Santa Cruz), anti-Flag M2 mAb, anti-GST pAb (Pharmacia Biotech), and anti-actin mAb (ICN). After incubation with horseradish peroxidase-conjugated antimouse or anti-rabbit IgG Ab (Amersham Pharmacia), immunoblots were exposed to the enhanced chemiluminescence (ECL) detection system (Amersham Pharmacia) according to the manufacturer's instructions.
Immunoprecipitations and ATM or ATR kinase assays
For immunoprecipitation of Flag-ATMwt, 500 mg of protein extracts were first incubated with 5.0 mg of anti-Flag M2 mAb (Sigma) and immunoprecipitated by anti-mouse IgG (whole molecule) agarose beads. Flag-ATM or Flag-ATR immunoprecipitates were washed twice in 1 Â ATM kinase buffer as described (Chan et al., 2000) . The kinase assay was initiated by adding 4 mg of the substrate GST-PHAS-I (Banin et al., 1998; Chan et al., 2000) , 1 mCi of [g-32 P]ATP (ICN), and 10 mm of MnCl 2 . After incubation at 301C for 30 min, the reactions were stopped by adding 2 Â SDS loading buffer, and the samples were analysed on SDS-PAGE and visualized by Coomasie blue staining and autoradiography. GST-PHAS-I protein levels in kinase reactions were also visualized by Western blotting with anti-GST antibody. To test 2-AP inhibition of kinase activity, 10, 5, or 2 mm of 2-AP was added to the kinase reactions.
FACS analysis and colony formation assays
HCT116 cells were plated at 7 Â 10 5 per 10-cm dish the day before. On the day of the experiment, cells were pretreated with or without 5 mm 2-AP for 2 h in fresh medium and then 0.34 mm AD was added for 3 h. This concentration of AD was previously shown to be the optimal one for HCT116 cells (Bunz et al., 1999) . After treatments, the cells were incubated in fresh medium for 24 h at 371C. Next, the cells were detached, fixed, and stained for FACS analysis as described (Lanni and Jacks, 1998) . For colony formation, HCT116 cells were plated in 10-cm plates at a density of 5 Â 10 4 cells per plate and grown for 16 h. Cells were then treated with 2-AP and AD as described for FACS analysis. Then the cells were replaced with fresh medium and incubated for 10-12 days. The medium was refreshed every 2 days. Then, the colonies on the plates were fixed by 3.7% formaldehyde and stained with crystal violet. This experiment was repeated at least three times.
Data quantification
All data quantifications were done using Scion Image software (Scion Corporations) following the program protocol.
